SCHEMBL9636934

SCHEMBL9636934

NC(CF)CCCOCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
TACR1 P25103 3/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HRH4 Q9H3N8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
EPHX1 P07099 1/20 0.38
IDO1 P14902 1/20 0.38
SLC1A1 P43005 1/20 0.38
NAAA Q02083 2/20 0.37
AGXT P21549 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA7 P43166 2/20 0.37
CA9 Q16790 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6120599 0.83 TSHR (0.45) TSHRTACR1TDP1L3MBTL1HRH4
SCHEMBL7312276 0.83 TSHR (0.45) TSHRTACR1TDP1L3MBTL1HRH4
SCHEMBL6120254 0.83 TSHR (0.45) TSHRTACR1TDP1L3MBTL1HRH4
SCHEMBL17747743 0.80 LTA4H (0.48) TSHRSLC1A1HTTSMN1; SMN2
SCHEMBL17747744 0.80 LTA4H (0.48) TSHRSLC1A1HTTSMN1; SMN2
SCHEMBL1923485 0.77 TSHR (0.45) TSHRTACR1TDP1L3MBTL1EPHX1
SCHEMBL25467792 0.76 TSHR (0.58) TSHRTDP1L3MBTL1HRH4HRH3
SCHEMBL8768910 0.75 SLC1A1 (0.57) TDP1SLC1A1HTTSMN1; SMN2
SCHEMBL8618292 0.75 SLC1A1 (0.57) TDP1SLC1A1HTTSMN1; SMN2
SCHEMBL2640223 0.75 TSHR (0.70) TSHRTDP1L3MBTL1HRH4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0326766-B1 5-SUBSTITUTED ORNITHINE DERIVATIVES MERRELL DOW PHARMACEUTICALS INC. (US) 1992-06-17 EP disclosed
US-4902719-A ORNITHINE DEFICIENCY TREATMENT MERRELL DOW PHARMACEUTICALS INC. (US) 1990-02-20 US disclosed
EP-0326766-A1 5-Substituted ornithine derivatives MERRELL DOW PHARMACEUTICALS INC. (US) 1989-08-09 EP disclosed